O'Connor sells Procore (PCOR) shares worth $1.14 million

Procore Technologies (PCOR) director Kevin J. O’Connor sold 15,717 shares totaling $1.14 million on July 9-10, 2025, via a pre-arranged 10b5-1 plan. This insider activity follows the construction software firm's strong Q1 2025 results, which surpassed revenue and EPS forecasts with $311 million and $0.23 respectively, alongside robust 28% RPO growth and impressive 81.2% gross margins. Despite the positive financials and optimistic Q2 guidance, analyst sentiment is mixed, with Stifel reducing its price target to $75 while maintaining a Buy rating, contrasting with Citizens JMP's reaffirmed $95 target and Market Outperform rating.

Analysis

Procore Technologies (PCOR) presents a complex picture of strong fundamental performance juxtaposed with mixed market signals. The company's first-quarter 2025 results were robust, with revenue of $311 million and EPS of $0.23 both exceeding consensus forecasts. This performance is underpinned by healthy forward-looking metrics, including a 28% year-over-year increase in total Remaining Performance Obligations (RPO) to $1.29 billion and impressive gross profit margins of 81.2%. However, this positive operational narrative is clouded by recent events. A company director, Kevin J. O’Connor, executed sales of 15,717 shares for approximately $1.14 million; while significant, these sales were conducted under a pre-arranged 10b5-1 plan, which typically mitigates concerns about opportunistic selling. Analyst sentiment is also divided, with Citizens JMP reaffirming a bullish $95 price target, while Stifel, despite maintaining a Buy rating, cut its target to $75. This caution may be linked to the company's Q2 guidance, which, at $310-$312 million in revenue, implies a sequential flattening and a growth deceleration to 9-10%, a potential point of concern for investors.

Key Decisions for Investors

• Investors should view the director's $1.14 million stock sale with caution but recognize it was executed under a pre-arranged 10b5-1 plan, which substantially mitigates the negative signal, especially given the director's significant remaining holdings.
• The primary focus should be on the conflicting signals between strong fundamentals, like the 28% RPO growth, and cautionary market indicators, such as Stifel's price target reduction from $93 to $75.
• Closely monitor upcoming corporate reports to validate whether the Q2 revenue guidance of $310-$312 million, which implies a sequential growth slowdown, is a temporary event or the start of a decelerating trend.